“Anakinra as Rescue Therapy to Treat Patients with Severe COVID-19 Refractory to Tocilizumab”, acbr, vol. 5, no. 6, pp. 972–982, Dec. 2021, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/14882